Catálogo de publicaciones - libros
Título de Acceso Abierto
Killing Cancer: Discovery and Selection of New Target Molecules
Resumen/Descripción – provisto por la editorial
No disponible.
Palabras clave – provistas por la editorial
ferlin; myoferlin; dysferlin; otoferlin; C2 domain; plasma membrane; sulconazole; NF-κB; IL-8; mammosphere; breast cancer stem cells; AF1Q; MLLT11; WNT; STAT; esophageal cancer; prognosis; mTORC1; mTORC2; metabolism; rapalogs; mTOR inhibitors; cancer metabolism; mTOR in immunotherapy; nutrient metabolism; kinase inhibitors; mTOR signaling; MAPK kinase; ERK1; ERK2; CD domain; Rolled; SCH772984; VRT-11E; sevenmaker; cancer therapy; EMT; lysosome; lysosome-mediated invasion; MZF1; phosphorylation; PAK4; SUMOylation; transcription factor; zinc finger; glucocorticoids; 3D growth; nuclear factor kappa-light-chain-enhancer of activated B-cells (NF-κB); epithelial–mesenchymal transition; anoikis; proliferation; targeted cancer therapy; disulfiram; NPL4; replication stress; DNA damage; BRCA1; BRCA2; ATR pathway; PDAC; TCIRG1; ATP6V0a3; invasion; migration; matrix degradation; pH-regulation; autophagy; multidrug resistance in cancer; drug efflux pumps; ATP-binding cassette transporter; breast cancer resistance protein (BCRP); ABCG2; pyrazolo-pyrimidine derivative; SCO-201; colorectal cancer; immunotherapy; inflammation; microsatellite instability; oncofetal chondroitin sulfate; chondroitin sulfate; cancer; solid tumors; target; pediatric cancer; VAR2; dexamethasone; thyroid cancer; microgravity; space environment; n/a
Disponibilidad
| Institución detectada | Año de publicación | Navegá | Descargá | Solicitá |
|---|---|---|---|---|
| No requiere | Directory of Open access Books |
|
Información
Tipo de recurso:
libros
ISBN electrónico
978-3-03943-441-1
País de edición
Suiza
Información sobre derechos de publicación
Unless otherwise agreed, edited books (book as a whole) are labeled as u201cOpen Accessu201d and licensed by the respective authors in accordance with the Creative Commons Attribution (CC BY-NC-ND) license. The license allows users to download, copy, and build upon published work non-commercially, as long as the author and publisher are properly credited. If the material is transformed or built upon, the resulting work may not be distributed. The source of the published text must be identified and the DOI of the book should be given. Unless otherwise agreed, articles and monographs are labeled as u201cOpen Accessu201d and licensed by the respective authors in accordance with the Creative Commons Attribution (CC BY) license. The u201cOpen Accessu201d license allows unlimited distribution and reuse as long as appropriate credit is given to the original source and any changes made compared to the original are indicated. The source of the published text must be identified and the DOI of the article should be given.
